Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors - PubMed (original) (raw)
Affiliations
- PMID: 9892189
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors
J A Biegel et al. Cancer Res. 1999.
Abstract
We examined 18 atypical teratoid and rhabdoid tumors of the brain and 7 renal and 4 extrarenal rhabdoid tumors for mutations in the candidate rhabdoid tumor suppressor gene, INI1. Fifteen tumors had homozygous deletions of one or more exons of the INI1 gene, and the other 14 tumors demonstrated mutations. Germ-line mutations of INI1 were identified in four children, one with an atypical teratoid tumor of the brain and three with renal rhabdoid tumors. These studies suggest that INI1 is a tumor suppressor gene involved in rhabdoid tumors of the brain, kidney, and other extrarenal sites.
Similar articles
- Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Biegel JA, et al. Clin Cancer Res. 2002 Nov;8(11):3461-7. Clin Cancer Res. 2002. PMID: 12429635 - Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.
Biegel JA, Fogelgren B, Wainwright LM, Zhou JY, Bevan H, Rorke LB. Biegel JA, et al. Genes Chromosomes Cancer. 2000 May;28(1):31-7. doi: 10.1002/(sici)1098-2264(200005)28:1<31::aid-gcc4>3.0.co;2-y. Genes Chromosomes Cancer. 2000. PMID: 10738300 - Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation.
Janson K, Nedzi LA, David O, Schorin M, Walsh JW, Bhattacharjee M, Pridjian G, Tan L, Judkins AR, Biegel JA. Janson K, et al. Pediatr Blood Cancer. 2006 Sep;47(3):279-84. doi: 10.1002/pbc.20622. Pediatr Blood Cancer. 2006. PMID: 16261613 - Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS, Judkins AR. Margol AS, et al. Cancer Genet. 2014 Sep;207(9):358-64. doi: 10.1016/j.cancergen.2014.07.004. Epub 2014 Aug 1. Cancer Genet. 2014. PMID: 25246033 Review. - A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature.
Coccé MC, Lubieniecki F, Kordes U, Alderete D, Gallego MS. Coccé MC, et al. J Neurooncol. 2011 Aug;104(1):375-80. doi: 10.1007/s11060-010-0478-0. Epub 2010 Dec 3. J Neurooncol. 2011. PMID: 21127945 Review.
Cited by
- Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study.
Martin-Liberal J, Garralda E, García-Donas J, Soto-Castillo JJ, Mussetti A, Codony C, Martin-Lluesma S, Muñoz S, Galvao V, Lostes J, Rotxes M, Prat-Vidal C, Palomero J, Muñoz A, Moreno R, García Del Muro X, Sureda A, Alemany R, Gros A, Piulats JM. Martin-Liberal J, et al. Future Oncol. 2024;20(32):2437-2445. doi: 10.1080/14796694.2024.2385287. Epub 2024 Aug 12. Future Oncol. 2024. PMID: 39129675 Clinical Trial. - Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumors.
Thomson G, Filser M, Guerrini-Rousseau L, Tauziede-Espariat A, Bourneix C, Gauthier-Villars M, Simaga F, Beccaria K, Faure-Conter C, Maureille A, Zattara-Cannoni H, Andre N, Entz-Werle N, Brugieres L, Mansuy L, Denizeau P, Julia S, Ingster O, Lejeune S, Brahimi A, Coupier I, Bonadona V, Delattre O, Masliah-Planchon J, Bourdeaut F. Thomson G, et al. Neuro Oncol. 2024 Nov 4;26(11):2102-2112. doi: 10.1093/neuonc/noae122. Neuro Oncol. 2024. PMID: 39093628 - Outcomes for children with recurrent/refractory atypical teratoid rhabdoid tumor: A single-institution study with molecular correlation.
Carey SS, Huang J, Myers JR, Mostafavi R, Orr BA, Dhanda SK, Michalik LH, Tatevossian RG, Klimo P Jr, Boop F, Lu C, Sioson E, Zhou X, Nichols KE, Merchant TE, Ellison DW, Robinson GW, Onar-Thomas A, Gajjar A, Upadhyaya SA. Carey SS, et al. Pediatr Blood Cancer. 2024 Oct;71(10):e31208. doi: 10.1002/pbc.31208. Epub 2024 Jul 21. Pediatr Blood Cancer. 2024. PMID: 39034595 - Chromatin remodellers as therapeutic targets.
Malone HA, Roberts CWM. Malone HA, et al. Nat Rev Drug Discov. 2024 Sep;23(9):661-681. doi: 10.1038/s41573-024-00978-5. Epub 2024 Jul 16. Nat Rev Drug Discov. 2024. PMID: 39014081 Review. - Synergistic Antitumor Activity of Talazoparib and Temozolomide in Malignant Rhabdoid Tumors.
Mironova E, Molinas S, Pozo VD, Bandyopadhyay AM, Lai Z, Kurmashev D, Schneider EL, Santi DV, Chen Y, Kurmasheva RT. Mironova E, et al. Cancers (Basel). 2024 May 28;16(11):2041. doi: 10.3390/cancers16112041. Cancers (Basel). 2024. PMID: 38893160 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases